idiopathic pulmonary fibrosis
Conditions
Interventions
Cravit IPF Group:Cravit 500 mg per time
Cravit Normal Pulmonary Function Group:Cravit 500 mg per time
Moxifloxacin IPF Group:Moxifloxacin 400mg per time
Moxifloxacin Normal PulmonaryFunction Group:Moxifloxacin 400mg per time
Sponsors
Respiratory Department, Peking Union Medical College Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: 1. Age: from 18 to 70 years; 2. Agenda: Male or Female; 3. Inpatient or outpatient; 4. Negative result in the pregnancy test; 5. Diagnosis as IPF and need to conduct the bronchoscope test.
Exclusion criteria
Exclusion criteria: 1. Serious heart, liver, and renal disease; 2. hormone or immunosuppressive agent treatment patients; 3. Serious gastrointestinal disease patients; 4. has used levofloxacin or other quinolone drugs seven days before enrollment; 5. Investigator thinks that there are any situations which will add the patient's risk or influence the study results. And so on.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Drug Concentration of BALF and blood after 3.5 hours treatment; | — |
Countries
China
Contacts
Public ContactZuo-jun Xu
Outcome results
None listed